Download Files:
AB-506
SKU
HY-148768-Get quote
Category Reference compound
Tags Anti-infection, HBV, Inflammation/Immunology
Products Details
Product Description
– AB-506 is an orally active inhibitor of HBV replication targeting the viral core protein. AB-506 can bind to HBV core protein, accelerate capsid assembly and inhibit HBV pgRNA encapsidation. AB-506 can be used in chronic hepatitis B (CHB) research[1].
Web ID
– HY-148768
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C21H18ClF2N5O3
References
– [1]Nagraj Mani, et al. Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein. Antiviral Res. 2022 Jan;197:105211.
CAS Number
– 2245020-50-0
Molecular Weight
– 461.85
SMILES
– ClC(C=C1NC(C2=C3C([C@H](CC3)NC(OCC4=NN(C)C=N4)=O)=C(C=C2)F)=O)=C(C=C1)F
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– HBV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.